Navigation Links
Opal Photoactivator™

ProductsOpal Photoactivator™
Company Lumenis Inc.
Item Opal Photoactivator™
Features 
  • Utilizes an advanced diode laser with consistent beam energy of 689 nanometers
  • Its modular design allows easy configuration to most diagnostic slit lamp platforms
  • Exposure time as determined by intensity, fluence, spot size, and contact lens magnification is typically only 83 seconds
  • Quality controls known as SmartLink and PowerCheck minimize the potential for inadequate drug activation
  • At-the-link power feedback, dual footswitch mode (continuous and staged), and a variable spot size of .4 to .8mm
  • Historic progress in treating AMD, pathologic myopia, and histoplasmosis
  • Only 83 seconds of low energy 689-nanometer light
  • Swift, office-based procedure
  • Only targets abnormal vessels, sparing normal vessels
  • A minimally invasive procedure
  • Received approval by FDA in April 2000
Description Until recently, most patients with age-related macular degeneration (AMD) could not expect their vision to improve or stabilize with or without treatment. Now, the Opal Photoactivator laser from Lumenis has revolutionized the standard of care and offers patients renewed hope.

Lumenis designed the Opal Photoactivator especially for use in photodynamic therapy with verteporfin, a drug produced by CIBA Vision Corporation, the eye care unit of Novartis AG. The Opal laser used in conjunction with Visudyne therapy represents an incredible advance in ocular photodynamic therapy (PDT). In this approach, the Opal laser is used not as a cutting tool but to activate a therapeutic drug in the patient's eye, providing a minimally invasive, focused treatment for AMD.

The Opal offers innovative features unavailable on any other laser -- features that ensure uncompromised treatment, safety, and patient care.

Info Lumenis Inc.
Customer Service: 877-lumenis
Web site: http://www.lumenis.com

Related medicine products :

1. Adson Cranial Rongeur
2. Bacon Cranial Rongeur
3. Instatrak - Cranial
4. Neuroclip Cranial Flap Fixation System
5. TEW Cranial/Spinal Retractor (A 1090)
6. De Vilbiss Cranial Rongeur
7. Stookey Cranial Rongeur
8. Marchac Cranial Rongeur
9. Cranial Drill
10. Hudson Cranial Drill
11. Tew Cranial/Spinal Retractor
...
...
Rhoton Curettes, titanium, length 191 mm, straight....
Sundt Slim-Line Temporary Vessel Clips used for temporary vascular occlusion during intracranial surgical procedures. Non-magnetic, MP35N, MRI compatible, gold color. Bayonet....
Medicine Products:
(Date:9/16/2014)... McLean, Va. (PRWEB) September 16, 2014 ... use through predictive analytics and targeted clinical programs, ... The announced changes support the Company’s drive to ... analytics and targeted clinical programs. On September 2, ... parent company, Millennium Health, announced that RxAnte founder ...
(Date:9/16/2014)... News) -- Illegal drug use among teens in the United ... report. Encouragingly, the new study also found that ... among young people between the ages of 12 and 17 ... of 70,000 people aged 12 and older across the United ... abuse problems among this age group also dropped from 8.9 ...
(Date:9/16/2014)... YORK, NY (September 16, 2014) The Columbia ... the 2014 Higher Education Excellence in Diversity (HEED) ... and largest diversity-focused publication in higher education. As ... honor recognizing U.S. colleges and universities that demonstrate ... be featured along with 82 other recipients in ...
(Date:9/16/2014)... September 15, 2014A prospective study that compared patient-reported ... with bone metastases demonstrates that single fraction radiation ... fraction radiation therapy (MFRT) when pain, function and ... presented today at the American Society for Radiation ... indicates that improvements in patients, pain, function and ...
(Date:9/16/2014)... September 16, 2014 Fresh shiitake ... iron and potassium. They are second-most consumed mushroom ... and their healing and health properties. , In ... Shiitakes can stimulate and strengthen the immune system ... contain polycharrides, including beta glucans . These ...
Breaking Medicine News(10 mins):Health News:Millennium Health’s RxAnte Subsidiary Announces Leadership Promotions 2Health News:Millennium Health’s RxAnte Subsidiary Announces Leadership Promotions 3Health News:Fewer U.S. Teens Using Illegal Drugs and Alcohol, Report Finds 2Health News:Columbia University College of Dental Medicine receives diversity award 2Health News:Columbia University College of Dental Medicine receives diversity award 3Health News:Columbia University College of Dental Medicine receives diversity award 4Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 3Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 4Health News:As Fall Schedules Settle In, Block Stress-Related Illness with Your Own Shiitake Mushroom Log Kit from Lost Creek Mushroom Farm 2Health News:As Fall Schedules Settle In, Block Stress-Related Illness with Your Own Shiitake Mushroom Log Kit from Lost Creek Mushroom Farm 3
... , MONDAY, March 21 (HealthDay News) -- A woman,s use ... risk of respiratory problems in her children, according to a ... use of birth control pills may increase the risk of ... said the authors of the new study. The researchers ...
... MONDAY, March 21 (HealthDay News) -- While the majority of ... generally satisfied years later, almost 40 percent are saddled with ... removed, a small, new Belgian study reveals. The finding ... the University of California, San Francisco that suggested gastric bypass ...
... Rockville, Md., March 21, 2011 As part of ... Pharmacopeial Convention (USP) is working with the Food and ... (CHPA) to update quality standards for widely used medicines ... an ambitious, long-term effort to assess written (or documentary) ...
... Health Sciences University is enrolling patients in a federally funded ... progression of kidney disease. "The question is, if you ... said Dr. Laura Mulloy, Chief of the GHSU Section of ... Intervention Trial, or SPRINT, funded by the National Institutes of ...
... change the balance of bacteria that naturally live in the ... Brain, Behavior, and Immunity . "These bacteria ... the immune response," said lead researcher Michael Bailey. ... number of gut microorganisms, according to scientists from The Ohio ...
... March, 2011 Alcohol use during pregnancy is common ... and development of exposed offspring. Despite warnings from the ... contemplating pregnancy, a recent survey by the National Birth ... drank alcohol at some time during their pregnancy, with ...
Cached Medicine News:Health News:Moms' Use of 'the Pill' Won't Raise Kids' Asthma Risk: Study 2Health News:40% of Gastric Banding Patients Have Complications 2Health News:40% of Gastric Banding Patients Have Complications 3Health News:40% of Gastric Banding Patients Have Complications 4Health News:Quality standards for widely used medicines strengthened 2Health News:Quality standards for widely used medicines strengthened 3Health News:Study examines whether lower blood pressure reduces kidney disease progression 2Health News:Adolescent offspring of women who drank alcohol during first trimester 2
(Date:9/16/2014)... , Sept. 16, 2014 Based ... closure market, Frost & Sullivan recognises Incisive Surgical ... for Customer Value Leadership. Incisive Surgical,s uniquely-designed, innovative ... technology that eliminates the need for patients to ... and staple removal  that may result in increased ...
(Date:9/16/2014)... , Sept. 16, 2014 CorMedix ... focused on developing and commercializing therapeutic products for ... infectious diseases, announces the amendment and restatement of ... preferred stock and related warrants, as well as ... stock and warrant financing, to remove anti-dilution, price ...
(Date:9/16/2014)... , Sept. 16, 2014  DNAtrix, Inc., experts ... first patient was treated with the company,s lead ... interferon in a randomized, multicenter, open-label Phase Ib ... "DNAtrix, in collaboration with leading neurosurgeons and neuro-oncologists ... initiation of our randomized Phase Ib study of ...
Breaking Medicine Technology:Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 2Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 3Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 4Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 5CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 3DNAtrix Announces Treatment Of First Patient With DNX-2401 In Recurrent Glioblastoma Trial 2